Literature DB >> 32761367

Chromosomal microarray should be performed for cases of fetal short long bones detected prenatally.

Keren Tzadikevitch Geffen1,2, Amihood Singer3, Idit Maya4, Lena Sagi-Dain5, Morad Khayat6, Shay Ben-Shachar7,8, Hagit Daum9, Rachel Michaelson-Cohen10, Michal Feingold-Zadok7,11, Rivka Sukenik Halevy7,4.   

Abstract

PURPOSE: To investigate the prevalence of pathogenic and likely-pathogenic variants detected by chromosomal microarray analysis (CMA), among pregnancies with fetal short long bones diagnosed by ultrasound.
METHODS: The study cohort was based on cases of chromosomal microarray analyses performed nationwide for the indication of short long bones.
RESULTS: CMA was performed in 66 cases of short long bones. There were 4 cases with a pathogenic/likely pathogenic result (6%). The rate of chromosomal abnormalities was significantly higher compared to the background risk for copy number variations (CNVs) in pregnancies with no sonographic anomalies (P < 0.001). The yield of CMA in our cohort was significantly higher for both isolated and non-isolated cases, for cases in which the lowest estimated bone length percentile was above the 3rd percentile (below 5th percentile), and for cases diagnosed with short long bones after 22 weeks but not for cases diagnosed after 24 weeks.
CONCLUSION: The yield of CMA in cases with short long bones (both isolated and non-isolated) is significantly higher than the background risk for chromosomal anomalies in pregnancies with no sonographic anomalies. This suggests that CMA should be offered in pregnancies with a diagnosis of fetal short long bones.

Entities:  

Keywords:  Chromosomal microarray analysis; Fetal short long bones; Growth percentile

Mesh:

Year:  2020        PMID: 32761367     DOI: 10.1007/s00404-020-05729-6

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  5 in total

1.  Trisomies and other chromosome abnormalities detected after positive sonographic findings.

Authors:  Artúr Beke; Csaba Papp; Ernõ Tóth-Pál; Gábor Mezei; József G Joó; Akos Csaba; Zoltán Papp
Journal:  J Reprod Med       Date:  2005-09       Impact factor: 0.142

Review 2.  Sotos syndrome 1 and 2.

Authors:  Juan F Sotos
Journal:  Pediatr Endocrinol Rev       Date:  2014-09

3.  Rates of chromosome abnormalities at different maternal ages.

Authors:  E B Hook
Journal:  Obstet Gynecol       Date:  1981-09       Impact factor: 7.661

4.  Prenatal midtrimester fetal long bone measurements and the prediction of small-for-gestational-age fetuses at term.

Authors:  Paul D Speer; Timothy Canavan; Hyagriv N Simhan; Lyndon M Hill
Journal:  Am J Perinatol       Date:  2013-05-20       Impact factor: 1.862

5.  Clinical value of genetic analysis in prenatal diagnosis of short femur.

Authors:  Jialiu Liu; Linhuan Huang; Zhiming He; Shaobin Lin; Ye Wang; Yanmin Luo
Journal:  Mol Genet Genomic Med       Date:  2019-09-30       Impact factor: 2.183

  5 in total
  3 in total

1.  Exome sequencing for structurally normal fetuses-yields and ethical issues.

Authors:  Hagit Daum; Tamar Harel; Talya Millo; Avital Eilat; Duha Fahham; Shiri Gershon-Naamat; Adily Basal; Chaggai Rosenbluh; Nili Yanai; Shay Porat; Doron Kabiri; Simcha Yagel; Dan V Valsky; Orly Elpeleg; Vardiella Meiner; Hagar Mor-Shaked
Journal:  Eur J Hum Genet       Date:  2022-09-07       Impact factor: 5.351

2.  Chromosomal Microarray Analysis in Pregnancies With Corpus Callosum or Posterior Fossa Anomalies.

Authors:  Lior Greenbaum; Idit Maya; Lena Sagi-Dain; Rivka Sukenik-Halevy; Michal Berkenstadt; Hagith Yonath; Shlomit Rienstein; Adel Shalata; Eldad Katorza; Amihood Singer
Journal:  Neurol Genet       Date:  2021-05-28

Review 3.  Molecular Approaches in Fetal Malformations, Dynamic Anomalies and Soft Markers: Diagnostic Rates and Challenges-Systematic Review of the Literature and Meta-Analysis.

Authors:  Gioia Mastromoro; Daniele Guadagnolo; Nader Khaleghi Hashemian; Enrica Marchionni; Alice Traversa; Antonio Pizzuti
Journal:  Diagnostics (Basel)       Date:  2022-02-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.